TrademarkDir
SERCA PHARMACEUTICALS
LIVE

Serial Number

79333099

Owner

SERCA PHARMACEUTICALS AS

Attorney

Susan Stabe

Filing Date

Dec 20, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SERCA PHARMACEUTICALS Trademark

Serial Number: 79333099 • Registration: 7215194

SERCA PHARMACEUTICALS is a trademark filed by SERCA PHARMACEUTICALS AS on December 20, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SERCA PHARMACEUTICALS AS

Gaustadalléen 21

Entity Type: 99

Trademark Details

Filing Date

December 20, 2021

Registration Date

November 14, 2023

Published for Opposition

August 29, 2023

Goods & Services

Treatment of materials for use in production of pharmaceuticals; production and custom manufacturing of pharmaceuticals; production and custom manufacturing of preparations for treatment of cardiovascular diseases, preparations for treatment of myocardial infarction, preparations for prophylactic treatment of cardiovascular diseases and preparations for prophylactic treatment of myocardial infarction; production and custom manufacturing of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparations

pharmaceutical preparations for treatment of cardiovascular diseases; pharmaceutical preparations for treatment of myocardial infarction; pharmaceutical preparations for prophylactic treatment of cardiovascular diseases; pharmaceutical preparations for prophylactic treatment of myocardial infarction; cardiovascular disease prophylactic preparations for preventing cardiovascular disease; myocardial infarction prophylactic preparations for preventing myocardial infarction

Promoting of pharmaceutical products; retail stores services featuring pharmaceutical products; promoting of pharmaceutical products for therapeutic treatment of cardiovascular diseases, products for therapeutic treatment of myocardial infarction, products for prophylactic treatment of cardiovascular diseases and products for prophylactic treatment of myocardial infarction; retail store services featuring pharmaceutical products for therapeutic treatment of cardiovascular diseases, products for therapeutic treatment of myocardial infarction, products for prophylactic treatment of cardiovascular diseases and products for prophylactic treatment of myocardial infarction; promoting of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparation; retail store services featuring cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparation

Research and development of pharmaceutical preparations for treatment of cardiovascular diseases, preparations for therapeutic treatment of myocardial infarction, preparations for prophylactic treatment of cardiovascular diseases and preparations for prophylactic treatment of myocardial infarction; research and development of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparations

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 17, 2025 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 24, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 24, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 24, 2025 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 4, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 14, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 14, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 14, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Aug 28, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 9, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 9, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 13, 2023 GPRN
PRIORITY ACTION E-MAILED
Apr 13, 2023 GPRA
PRIORITY ACTION WRITTEN
Apr 13, 2023 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2023 TROA
REFUSAL PROCESSED BY IB
Dec 28, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 7, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 7, 2022 RFRR
ATTORNEY REVIEW COMPLETED
Nov 17, 2022 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Oct 26, 2022 CREV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 7, 2022 ADCH
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 26, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2022 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 23, 2022 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
May 28, 2022 NREP
APPLICATION FILING RECEIPT MAILED
Feb 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 10, 2022 REPR

Related Trademarks